Abbott received FDA approval for an expanded indication for its Deep Brain Stimulation system, to include targeting of internal globus pallidus. The GPi plays an integral role in the motor function. When targeted with...
Helen Mayberg at Mount Sinai has published a study showing that deep brain stimulation of the subcallosal cingulate provides a lasting antidepressant effect in treatment-resistant depression. According to Mayberg: “Over eight years of observation, most of our...
University of Washington’s Dror Ben Zeev has published a paperdetailing a wide array of phone-based technology meant to support the recovery of psychosis throughout life — from early detection to symptom management to vocational rehabilitation, The...
Georgia Tech’s Woon-Hong Yeo has developed a 3D-printed, stretchable, battery-free, wireless sensor, implanted in brain blood vessels to measure incoming blood flow, to evaluate aneurysm healing. The tiny device wraps around stents or diverters implanted to...
Klaus Gerwertat Ruhr-Universität Bochum has developed a blood + CSF test that he claims can detect Alzheimer’s disease 8 years before the onset of symptoms. The goal is early stage therapy to achieve better results...
Richard Hanbury discussed Sana Health‘s pain management technology at Wearable Tech + Digital Health + Neurotech Silicon Valley, on February 22, 2019 at Stanford. ApplySci was delighted that CNBC chose to film this segment at...
Edward Changand UCSF colleagues are developing technology that will translate signals from the brain into synthetic speech. The research team believes that the sounds would be nearly as sharp and normal as a real person’s voice....
Charles Marmar, Adam Brown, and NYU colleagues are using AI-based voice analysis to detect PTSDwith 89 per cent accuracy, according to a recent study. PTSD is typically determined by bias-prone clinical interviews or self-reports. The team recorded standard...
NeuroSigmahas received FDA clearance for its forehead patch which stimulates the trigeminal nerve during sleep to treat ADHD. The device won CE Mark approval in Europe in 2015. The approval was based on studyof 62 subjects. Over four weeks, those...
Led by Justin Sanchez, DARPA’s SUBNETSprogram develops responsive, adaptable, personalized closed-loop therapies for neuropsychiatric illness that incorporate recording and analysis of brain activity with near-real-time neural stimulation to correct or mitigate brain dysfunction. The technology...